Literature DB >> 19819188

Effects of scoliosis on respiratory muscle strength in patients with neuromuscular disorders.

Deniz Inal-Ince1, Sema Savci, Hulya Arikan, Melda Saglam, Naciye Vardar-Yagli, Meral Bosnak-Guclu, Deniz Dogru.   

Abstract

BACKGROUND CONTEXT: Neuromuscular disorders (NMD) are characterized by loss of lung volume and respiratory muscle weakness, but the effects of scoliosis on lung function are unclear.
PURPOSE: To compare pulmonary function and respiratory muscle strength in patients with NMD with and without scoliosis as well as in healthy controls. STUDY DESIGN/
SETTING: Prospective comparison of pulmonary function testing and respiratory muscle strength were made at the pediatric pulmonology and cardiopulmonary rehabilitation units of a university hospital. PATIENT SAMPLE: Twenty-two patients with NMD and scoliosis, 17 patients with NMD without scoliosis, and 24 age- and sex-matched healthy controls. Outcome measures were compared in patients with NMD with and without scoliosis and healthy subjects using Student t test, Mann-Whitney U test, chi-square test, one-way analysis of variance (ANOVA), Kruskal-Wallis one-way ANOVA, Pearson correlation coefficients, and Spearman rank correlation, as appropriate. OUTCOME MEASURES: 1) Pulmonary function: forced vital capacity (FVC), forced expiratory volume in 1 second (FEV(1)), peak expiratory flow rate (PEF), forced expiratory flow between 25% and 75% of FVC (FEF(25-75%)), and maximum expiratory flows at 75%, 50%, and 25% of FVC (MEF(75), MEF(50), and MEF(25), respectively); 2) oxygen saturation: pulse oxymeter reading; and 3) respiratory muscle strength: maximal inspiratory mouth pressure (MIP) and maximal expiratory mouth pressure (MEP).
METHODS: Pulmonary function, oxygen saturation, MIP, and MEP were measured and compared in patients with NMD, patients with and without scoliosis, and in healthy subjects.
RESULTS: The patients with NMD, both with and without scoliosis, had significantly lower PEF, MIP, MEP, % predicted MIP (%MIP), and % predicted MEP (%MEP) than those of healthy subjects (p<.05). The patients with NMD and scoliosis had significantly lower values than those with NMD without scoliosis and controls (p<.05) for FVC, FEV(1), and FEF(25-75%).
CONCLUSION: Both inspiratory and expiratory muscle strength were diminished in patients with NMD compared with healthy controls. Significant differences were also noted in pulmonary function in patients with NMD with or without scoliosis. This suggests that NMD may impact respiratory function independently of the effects of scoliosis. Clinicians treating patients with NMD should be aware of the possibility of compromised respiratory function in these patients to address possible complications.

Entities:  

Mesh:

Year:  2009        PMID: 19819188     DOI: 10.1016/j.spinee.2009.08.451

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  11 in total

Review 1.  Influenza vaccination and treatment in children with neurologic disorders.

Authors:  Fiona Havers; Alicia Fry; Georgina Peacock; Lyn Finelli
Journal:  Ther Adv Vaccines       Date:  2014-07

2.  The impact of posterior temporary internal distraction on stepwise corrective surgery for extremely severe and rigid scoliosis greater than 130°.

Authors:  Hui-Min Hu; Hua Hui; Hai-Ping Zhang; Da-Geng Huang; Zhong-Kai Liu; Yuan-Ting Zhao; Si-Min He; Xue-Fang Zhang; Bao-Rong He; Ding-Jun Hao
Journal:  Eur Spine J       Date:  2015-06-14       Impact factor: 3.134

3.  Risk Factors for Severe COVID-19 in Children.

Authors:  Rebecca C Woodruff; Angela P Campbell; Christopher A Taylor; Shua J Chai; Breanna Kawasaki; James Meek; Evan J Anderson; Andy Weigel; Maya L Monroe; Libby Reeg; Erica Bye; Daniel M Sosin; Alison Muse; Nancy M Bennett; Laurie M Billing; Melissa Sutton; H Keipp Talbot; Keegan McCaffrey; Huong Pham; Kadam Patel; Michael Whitaker; Meredith L McMorrow; Fiona P Havers
Journal:  Pediatrics       Date:  2021-12-22       Impact factor: 9.703

4.  Respiratory functional and motor control deficits in children with spinal cord injury.

Authors:  Goutam Singh; Andrea L Behrman; Sevda C Aslan; Shelley Trimble; Alexander V Ovechkin
Journal:  Respir Physiol Neurobiol       Date:  2017-10-28       Impact factor: 1.931

5.  [Pulmonary function of children with acute leukemia in maintenance phase of chemotherapy].

Authors:  Thalita Medeiros Fernandes de Macêdo; Tania Fernandes Campos; Raquel Emanuele de França Mendes; Danielle Corrêa França; Gabriela Suéllen da Silva Chaves; Karla Morganna Pereira Pinto de Mendonça
Journal:  Rev Paul Pediatr       Date:  2014-12

6.  Reference Equation for Respiratory Pressures in Pediatric Population: A Multicenter Study.

Authors:  Fernanda Cordoba Lanza; Mara Lisiane de Moraes Santos; Jessyca Pachi Rodrigues Selman; Jaksoel Cunha Silva; Natalia Marcolin; Jeniffer Santos; Cilmery M G Oliveira; Pedro Dal Lago; Simone Dal Corso
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

7.  The lifetime risk of pneumonia in patients with neuromuscular scoliosis at a mean age of 21 years: the role of spinal deformity surgery.

Authors:  Heli Keskinen; Heikki Lukkarinen; Katariina Korhonen; Tuomas Jalanko; Antti Koivusalo; Ilkka Helenius
Journal:  J Child Orthop       Date:  2015-09-08       Impact factor: 1.548

8.  Differences of the Truncal Expansion and Respiratory Function between Children with Spastic Diplegic and Hemiplegic Cerebral Palsy.

Authors:  Yong Hyun Kwon; Hye Young Lee
Journal:  J Phys Ther Sci       Date:  2014-01-08

Review 9.  The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?

Authors:  Robin Lachmann; Benedikt Schoser
Journal:  Orphanet J Rare Dis       Date:  2013-10-12       Impact factor: 4.123

Review 10.  Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.

Authors:  Benedikt Schoser; Edward Fong; Tarekegn Geberhiwot; Derralynn Hughes; John T Kissel; Shyam C Madathil; David Orlikowski; Michael I Polkey; Mark Roberts; Harm A W M Tiddens; Peter Young
Journal:  Orphanet J Rare Dis       Date:  2017-03-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.